Redcare Pharmacy NV (RDC.DE)
EUR 139.9
(-3.38%)
EUR 139.9
(-3.38%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.63 EUR | 85.42% |
| 2022 | -4.32 EUR | -4.1% |
| 2021 | -4.15 EUR | -254.7% |
| 2020 | -1.17 EUR | 57.91% |
| 2019 | -2.78 EUR | 0.36% |
| 2018 | -2.79 EUR | -24.0% |
| 2017 | -2.25 EUR | -10.84% |
| 2016 | -2.03 EUR | -75.0% |
| 2015 | -1.16 EUR | -107.14% |
| 2014 | -0.56 EUR | -80.65% |
| 2013 | -0.31 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.39 EUR | -39.29% |
| 2024 Q2 | -0.21 EUR | 46.15% |
| 2023 Q1 | -0.55 EUR | -1.85% |
| 2023 Q3 | 0.41 EUR | 270.83% |
| 2023 Q2 | -0.24 EUR | 56.36% |
| 2023 Q4 | -0.28 EUR | -168.29% |
| 2023 FY | - EUR | 85.42% |
| 2022 Q3 | -1.11 EUR | 18.38% |
| 2022 Q4 | -0.54 EUR | 51.35% |
| 2022 FY | - EUR | -4.1% |
| 2022 Q1 | -1.27 EUR | 45.96% |
| 2022 Q2 | -1.36 EUR | -7.09% |
| 2021 Q1 | -0.32 EUR | 21.95% |
| 2021 Q2 | -0.63 EUR | -96.88% |
| 2021 Q3 | -0.81 EUR | -28.57% |
| 2021 FY | - EUR | -254.7% |
| 2021 Q4 | -2.35 EUR | -190.12% |
| 2020 Q3 | - EUR | 100.0% |
| 2020 FY | - EUR | 57.91% |
| 2020 Q4 | -0.41 EUR | 0.0% |
| 2020 Q2 | -0.01 EUR | 96.86% |
| 2020 Q1 | -0.37 EUR | 15.91% |
| 2019 Q2 | -0.52 EUR | 57.38% |
| 2019 FY | - EUR | 0.36% |
| 2019 Q1 | -1.22 EUR | -38.64% |
| 2019 Q4 | -0.44 EUR | 0.0% |
| 2019 Q3 | - EUR | 100.0% |
| 2018 Q4 | -0.88 EUR | 0.0% |
| 2018 FY | - EUR | -24.0% |
| 2018 Q1 | -0.67 EUR | 8.22% |
| 2018 Q2 | - EUR | 100.0% |
| 2018 Q3 | - EUR | 0.0% |
| 2017 Q1 | -0.60 EUR | 42.31% |
| 2017 Q2 | -0.30 EUR | 50.0% |
| 2017 Q4 | -0.73 EUR | -97.3% |
| 2017 Q3 | -0.37 EUR | -23.33% |
| 2017 FY | - EUR | -10.84% |
| 2016 Q4 | -1.04 EUR | -235.48% |
| 2016 Q3 | -0.31 EUR | 40.38% |
| 2016 Q2 | -0.52 EUR | -30.0% |
| 2016 Q1 | -0.40 EUR | 48.05% |
| 2016 FY | - EUR | -75.0% |
| 2015 Q1 | -0.39 EUR | 0.0% |
| 2015 FY | - EUR | -107.14% |
| 2015 Q2 | -0.39 EUR | 0.0% |
| 2015 Q4 | -0.77 EUR | 0.0% |
| 2015 Q3 | - EUR | 100.0% |
| 2014 FY | - EUR | -80.65% |
| 2013 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Newron Pharmaceuticals S.p.A. | -0.91 EUR | 30.769% |